US Stock MarketDetailed Quotes

EVGN Evogene

Watchlist
  • 1.5470
  • +0.0670+4.53%
Close Feb 14 16:00 ET
10.08MMarket Cap-0.35P/E (TTM)

About Evogene Company

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Company Profile

SymbolEVGN
Company NameEvogene
Listing DateNov 21, 2013
Founded1999
CEOMr. Ofer Haviv
MarketNASDAQ
Employees142
Fiscal Year Ends12-31
Address13 Gad Feinstein Street,Park Rehovot
CityRehovot
ProvinceHaMerkaz
CountryIsrael
Zip Code7638517
Phone972-8-931-1900

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Dan J. Gelvan, PhD
  • Chief Executive Officer; Ag Plenus Ltd.
  • --
  • Dr. Elran Haber, PhD
  • Chief Executive Officer; Biomica Ltd.
  • 339.00K
  • Yoash Zohar
  • Chief Executive Officer; Casterra Ag Ltd.
  • --
  • Amit Noam
  • Chief Executive Officer; Lavie Bio Ltd
  • --
  • Ofer Haviv
  • President; Chief Executive Officer of Company and Canonic Ltd.
  • 401.00K
  • Yaron Eldad
  • Chief Financial Officer
  • --
  • Dr. Nir Arbel
  • Chief Product Officer
  • 292.00K
  • Mark Kapel
  • Chief Technology Officer
  • --
  • Sassi Masliah
  • Vice President, Corporate Development
  • --
  • Eyal Ronen
  • Executive Vice President; Business Development
  • --
  • Sarit Firon
  • Chairman of the Board
  • --
  • Dr. Adrian Percy, B.Sc. ,M. Sc.,PhD
  • Independent Director
  • --
  • Professor Dr. Oded Shoseyov, PhD
  • Independent Director
  • --
  • Dan Falk
  • Independent Director
  • --
  • Leon Y. Recanati
  • Independent Director
  • --
  • Nir Nimrodi
  • Independent Director
  • --

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More